Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S L, Seagren"'
Autor:
H, Kreisman, A, Lisbona, L, Olson, K J, Propert, C, Modeas, R O, Dillman, S L, Seagren, M R, Green
Publikováno v:
Cancer. 72(5)
Patients with Stage III non-small cell lung cancer (NSCLC) whose cases are staged or treated surgically have different prognoses, depending on the substage (IIIa, IIIb). It is not known whether the prognostic differences apply to clinically staged no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::acf5053c017a42c82e468cdf717a7479
https://pubmed.ncbi.nlm.nih.gov/8394201
https://pubmed.ncbi.nlm.nih.gov/8394201
Autor:
S L, Seagren
Publikováno v:
Hematology/oncology clinics of North America. 4(6)
Radical radiotherapy of lung cancer has been studied for over 30 years. Results of early trials are often cited to justify a wait-and-see approach for all nonresectable patients. Because of more accurate staging, better radiotherapy treatment plannin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84ddbe239762ba2b2cfb41ac70f612e5
https://pubmed.ncbi.nlm.nih.gov/2286600
https://pubmed.ncbi.nlm.nih.gov/2286600
Autor:
Eric J. Small, Dean F. Bajorin, Ben L. Sanford, Susan Halabi, James N. Atkins, A. L. Himelstein, S. L. Seagren, Raymond J. Hohl, Jonathan E. Rosenberg
Publikováno v:
Journal of Clinical Oncology. 24:4582-4582
4582 Background: No standard 2nd-line chemotherapy exists for metastatic TCC. Response rates to 2nd-line chemotherapy for advanced TCC are low and response duration tends to be short. Bortezomib is a proteasome inhibitor with preclinical activity aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6c616a910093693f648c77ea3e49f44
https://doi.org/10.1200/jco.2006.24.18_suppl.4582
https://doi.org/10.1200/jco.2006.24.18_suppl.4582
Publikováno v:
Bronchology: Research, Diagnostic, and Therapeutic Aspects ISBN: 9789400982383
Symptomatic endobronchial recurrence of bronchogenic carcinoma in the previously heavily irradiated patient presents a difficult therapeutic challenge. External radiation is usually palliative when a patient is suffering from hemoptysis or airway obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::007330516a2d026712290398b7598e3e
https://doi.org/10.1007/978-94-009-8236-9_163
https://doi.org/10.1007/978-94-009-8236-9_163
Autor:
S L, Seagren, T R, Sharp
Publikováno v:
The Western journal of medicine. 130(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0edb1860aab65dc86c762973e4b0540
https://pubmed.ncbi.nlm.nih.gov/516674
https://pubmed.ncbi.nlm.nih.gov/516674
Autor:
S L, Seagren
Publikováno v:
Medical times. 107(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70c3d5506e4039c8dd7e6f35885f01ca
https://pubmed.ncbi.nlm.nih.gov/221775
https://pubmed.ncbi.nlm.nih.gov/221775
Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung
Autor:
J A, Young, R O, Dillman, S L, Seagren, R, Taetle, R E, Rentschler, J W, Lea, T J, Lehar, M R, Green, W, Stanton, J, Mendelsohn, I, Royston
Publikováno v:
Cancer treatment reports. 66(6)
Fifty-six patients with small cell carcinoma of the lung were treated with a two-cyclic induction course of hexamethylmelamine, vincristine, doxorubicin, and cyclophosphamide. Patients with limited disease (LD) who responded and patients with extensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cbf41eb8e43b9179d4f4360c9193c7f
https://pubmed.ncbi.nlm.nih.gov/6282459
https://pubmed.ncbi.nlm.nih.gov/6282459
Autor:
S L, Seagren, J E, Byfield
Publikováno v:
Medical and pediatric oncology. 3(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c22f4c33fb732b1b5cd49226545f6cfa
https://pubmed.ncbi.nlm.nih.gov/200833
https://pubmed.ncbi.nlm.nih.gov/200833